Biotech firms are turning to artificial intelligence to boost productivity and address talent shortages. Insilico Medicine is building a multi‑task AI platform that can generate disease hypotheses, design candidate molecules and even repurpose existing drugs, aiming to speed drug discovery and cut costs. GenEditBio is using AI to design engineered protein delivery vehicles that target specific tissues for in‑vivo CRISPR therapy, recently receiving FDA clearance for a corneal‑dystrophy trial. Both companies stress the need for richer, more diverse data to improve model accuracy and envision future tools such as digital twins for virtual clinical testing. Leer más →

Medical ethicists and AI researchers caution that artificial‑intelligence surrogates, designed to aid patient‑centered decisions, must be treated as decision aids rather than replacements for human judgment. While such tools could integrate clinical data, patient values, and contextual information, concerns arise over fairness, bias, emotional manipulation, and the need for automatic ethics review. Researchers stress rigorous validation, transparent conversation, and safeguards before deploying AI surrogates in critical care scenarios. Leer más →